Selected key takeaway from our 2026 Annual Conference: AI Support in Clinical Decision Making presented by Arsela Prelaj. Full recordings and presentations available to members on our website. #LCSM #lungcancer

Selected key takeaway from our 2026 Annual Conference: AI Support in Clinical Decision Making presented by Arsela Prelaj. Full recordings and presentations available to members on our website. #LCSM #lungcancer
👉 In this #ESMOGuidelines webinar, we explore the ESMO Clinical Practice Guidelines for early stage and locally advanced #NSCLC, applying key recommendations to a real-world case in multidisciplinary #LungCancer care
✨ Program Spotlight: LungMATCH
Your treatment options can be complicated. You don't have to navigate them alone.
LungMATCH provides personalized guidance on biomarkers, treatment options & clinical trials to help people impacted by #LungCancer feel more informed & prepared.
When you sign up for a Free to Breathe Walk and make an impact by raising $100 or more, you can wear your support for #LungCancer research! This year's walk t-shirt honors all of our connections and celebrates what we create when we walk together. Sign up at LCRF.org/anywhere or LCRF.org/chicago.
Thank you to Boehringer Ingelheim for being a generous sponsor and partner of the Free to Breathe National Walk Program!
#MSD and #DaiichiSankyo's regulatory efforts for their antibody-drug conjugates (#ADCs) for cancer have stuttered again, with a withdrawn filing for #lungcancer candidate ifinatamab deruxtecan (I-DXd) in the US.
After treatment for #SCLC #lungcancer, patients often undergo prophylactic #radiotherapy to prevent #metastases in the brain. Now, a new study presented by Chad Rusthoven, MD, from 🇺🇸 @cumedicalschool.bsky.social at @iaslc.bsky.social's #WCLC26, shows that #MRI surveillance alone is enough.
The Free to Breathe Chicago Walk to support #LungCancer research is just 3 weeks away! Join us Sunday, Oct 18 at Montrose Harbor. Sign up at LCRF.org/chicago!
🫁 Join the upcoming Lung Webinar for expert insights into combining RT and immunotherapy, from timing and dose to advanced RT techniques.
📅 13 Oct | 16:30–18:00 CEST | Online
👉 Register: https://bit.ly/4hKH8D8
Another view of the robotic single-port system! This tool allows us to perform complex thoracic surgeries through just one incision, reducing pain, recovery time, and hospital stays. It offers a level of precision that supports safer outcomes for our patients.
#thoracic #roboticsurgery #lungcancer
Never smoked a cigarette? You could still be at higher risk for lung cancer
replaye.com/never-smoked...
People with #LungCancer should not have to coordinate every part of their care themselves.
Today at #WCC2026, our VP presented collab work with LCPN on patient navigation: practical support to help people move between services and get the care they need.
A special thanks to all of the local and national sponsors for this weekend's Free to Breathe Kansas City Walk! #FreeToBreathe #LungCancer #ThankYou
Fourteen years after being diagnosed with stage 4 #LungCancer, Diane is here because of research! A clinical trial gave her a treatment that is now FDA-approved and has allowed her to keep living life to the fullest. She walks so others facing a diagnosis can have that same chance. LCRF.org/walk
1 in 17 women will develop #LungCancer in her lifetime. Do you know your #diagnostics and screening options? This #WorldLungDay, explore SWHR’s fact sheet about the different tests used to diagnose lung cancer: https://ow.ly/UVp450ZQkeK. #SWHRtalksCancer #SWHRtalksDiagnostics
LCRF’s annual gala Sept. 23 celebrated scientific discovery and the remarkable people who have contributed to the progress being made in the #LungCancer space. This year's gala spotlighted women and honored Rose Ann Weinstein and Dr. Narjust Florez for their tremendous work. LCRF.org/gala26
Selected key takeaway from our 2026 Annual Conference: AI in Pathological Diagnosis of Lung Cancer presented by Mehrdad Rakaee. Full recordings and presentations available to members on our website. #LCSM #lungcancer
Efficacy and safety of omitting the clinical target volume in limited-stage small cell #LungCancer: a large-scale multicenter real-world study. www.thegreenjournal.com/article/S016...
Real-world use of G-CSF primary prophylaxis in small cell #LungCancer: secondary data analysis from the French national cohorts KBP-2020-CPHG and ESCAP-2020-CPHG. link.springer.com/article/10.1...
Annual Report to the Nation on the Status of Cancer, featuring 21st century progress against #LungCancer. acsjournals.onlinelibrary.wiley.com/doi/10.1002/...